Renal

Renal (Kidney) Cancer Treatment Trials

Protocol
Number

Title

ID

ARGOS
AGS
003-007

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Learn more.

NCT01582672
SLHN
2011-113
Altor
BioScience

A Phase Ib/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Learn more.

NCT01326871

ACCELERON
A041-04
SLUHN
2014-56

A Phase 2 Randomized, Double-Blind Study of Dalantercept and Axitinib Compared to Placebo and Axitinib in Patients With Advanced Renal Cell Carcinoma

Learn more.

NCT01727336
Rexahn
SLUHN
2014-90

A Multicenter, Open-label, Phase 1b/2 Study to Evaluate the Safety and Efficacy of
RX-0201 in Combination With Everolimus to Treat Subjects With Advanced Renal
Cell Carcinoma

Learn more.

NCT02089334